Theratechnologies Profit Margin

The latest profit margin for THTX is -10.85% as of May 2025. That compares with -8.44% in the prior-year period — down 28.7% year over year. That is below the Healthcare sector average of 19.13%. Investors often review this figure alongside Theratechnologies's historical trend and sector peers before judging valuation or financial health.

Over the past year, THTX's profit margin moved from -8.44% to -10.85% — a 28.7% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Theratechnologies's valuation or profitability profile.

Against Healthcare companies, THTX currently prints -10.85% for profit margin, while the sector average sits near 19.13%. That is roughly 156.7% below the sector mean. Large gaps often invite a closer look at Theratechnologies's growth, margins, and balance sheet.

Profit Margin shows how effectively Theratechnologies converts resources into returns. At -10.85%, THTX may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -8.44% in the prior-year period — down 28.7% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting THTX's profit margin (-10.85%), review year-over-year change from -8.44%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.